Latest Breaking News On - Matt scalo - Page 13 : comparemela.com

Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial

SALT LAKE CITY, Aug. 08, 2023 (GLOBE NEWSWIRE) Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, part of the Intermountain

United statesGlenn farrellBrad gillmanMatt scaloMichael lyonsJason gillmanCancer research groupChildren oncology groupNational cancer instituteCancer research networkNational clinical trials networkNational institutes of healthOncology solutionsExchange commissionIntermountain precision genomics health operationsIntermountain health

Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status

Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesHolly johnsonGlenn farrellMatt scaloGenetics incAmerican lung associationExchange commissionCenters for diseaseMyriad geneticsMedical affairsDisease controlGenesight psychotropicPrivate securities litigation reform actAnnual reportQuarterly reportsCurrent reports

Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status

Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMatt scaloHolly johnsonGlenn farrellGenetics incExchange commissionAmerican lung associationCenters for diseaseGenetics announces enhancementsMedical affairsDisease controlGenesight psychotropicMyriad geneticsPrivate securities litigation reform actAnnual reportQuarterly reports

Myriad Genetics, Inc (NASDAQ:MYGN) Q2 2023 Earnings Call Transcript

Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2023 Earnings Call Transcript August 3, 2023 Operator: Greetings, and welcome to the Myriad Genetics Second Quarter 2023 Financial Earnings Call [Operator Instructions]. As a reminder, this conference is being recorded Thursday, August 3, 2023. I’d now like to turn the call over to Matt Scalo, Senior Vice President, Investor […]

Salt lake cityUnited statesMatt scaloNicole lambertPaul diazBracanalysis cdxBryan riggsbeeWells fargoSouth sanNet promoter scoreSouth san franciscoInvestor dayMyriad geneticsMyriad completeInvestor relationAnalysts are cutting price targets

Myriad Genetics to Release Second Quarter Financial Results on Aug 3, 2023

Myriad Genetics to Release Second Quarter Financial Results on Aug 3, 2023
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Glenn farrellMatt scaloGenetics incMyriad genetics